Abstract:Objective. Elevated plasma bile acids after bariatric surgery are thought to explain type 2 diabetes mellitus (T2DM) remission. Bile acids can bind to and activate the nuclear receptor famesoid-X receptor (FXR) by regulating lipid and glucose metabolism. We performed a surgical procedure (ligation of the common bile duct and external biliary drainage [LBD]) in the diabetic Goto-Kakizaki (GK) rat in order to investigate its effect on bile acids metabolism and T2DM mitigation.Material/Methods. LBD surgery and sham control surgery were performed on diabetic GK rats. The concentrations of total bile acids and blood glucose were analyzed by an automatic analyzer. Intraperitoneal glucose tolerance test (IPGTT) and insulin tolerance test (ITT) were used to monitor blood glucose level. Expression of genes involved in bile acid metabolism (FXR, CYP7A, et al.) and glycolipid metabolism (G6Pase, PEPCK, et al) was analyzed using qRT-PCR. The protein levels of pAKT, AKT and pGSK3 beta were tested by western blot. The morphological alterations of the liver and epididymal fat were monitored by H&E staining.Results. LBD increased plasma total bile acids, improved hepatic insulin sensitivity, and eventually mitigated T2DM, whereas food intake and body weight were unaltered. Post-LBD, the levels of total bile acids were elevated from 24.80 +/- 7.12 to 61.44 +/- 6.40 and the concentration of fast blood glucose was decreased from 204.7 +/- 11.06 mg/dL to 109.3 +/- 5.4 mg/dL. IPGTT and ITT showed that LBD operation improved insulin sensitivity in GK rats. Clusters of FXR signaling target genes were altered in the liver, such as FXR, CYP7A,G6Pase and PEPCK. These contributed to sustained bile acid homeostasis, and they ameliorated hepatic endoplasmic reticulum (ER) stress, increased energy expenditure, and reduced gluconeogenesis, resulting in a substantial improvement in hepatic insulin sensitivity. LBD also significantly reduced epididymal fat tissue and decreased the size of adipocytes.Conclusion. These results demonstrate that the elevated bile acids observed in LBD-operated GK rats link insulin sensitivity improvement to T2DM mitigation, recapitulating the metabolic effects of bariatric surgery. Our investigation establishes a model for a focused study of bile acids in the context of bariatric surgery that may contribute to the identification of therapeutics for T2DM. (C) 2015 Elsevier Inc. All rights reserved.

Influence of ursodeoxycholic acid on blood glucose, insulin and GLP-1 in rats with liver fibrosis induced by bile duct ligation

Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling

Effects of Ursodeoxycholic Acid on Intrahepatic Cholestasis in Rats

The Role of Bile Acid in Improving Glucose Tolerance of Non-Obese Diabetic Rats after Proximal Small Bowel Bypass

The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation

Effect of Ursodeoxycholi acid on liver cirrhosis with hepatitis B

Effects of Compound Ursodeoxycholic Acid Oral Liquid on Hepatic Fibrosis in Rats

Bile acids and their effects on diabetes

[Influence of Ursodeoxycholic Acid on the Therapeutic Effects of Low-Calorie Diet in Obesity and Hyperlipidemia Rats with Steatohepatitis].

[Ursodeoxycholic Acid Promotes Liver Regeneration after Partial Hepatectomy in Bile Duct Obstructive Rats].

Effect of Compound Ursodeoxycholic Acid Oral Liquid on Alcoholic Fatty Liver Disease in Rats

Ursodeoxycholic Acid Accelerates Bile Acid Enterohepatic Circulation

Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity.

Glycoursodeoxycholic Acid Ameliorates Diet-Induced Metabolic Disorders with Inhibiting Endoplasmic Reticulum Stress.

Clinical Efficacy of Ursodesoxycholic Acid for the Treatment of Primary Biliary Cirrhosis: a Meta-analysis

Effect of ursodeoxycholic acid administration after liver transplantation on serum liver tests and biliary complications: a randomized clinical trial.

Advances in Study of Ursodeoxycholic Acid in the Treatment of Primary Biliary Cirrhosis

Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion

Type 2 Diabetes Mitigation in the Diabetic Goto–Kakizaki Rat by Elevated Bile Acids Following a Common-Bile-duct Surgery

A molecular mechanism of UDCA engagement with GPBAR and subsequent G protein interaction revealed by scattered alanine scanning

Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism